CIM
NTUS

Contravisory Investment Management’s Natus Medical Inc NTUS Stock Holding History

Contravisory Investment Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-27
Closed -$1K – 482
2017
Q4 		$1K Hold
27
– – ﹤0.01% 406
2017
Q3 		$1K Buy
+27
New +$953 ﹤0.01% 460

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return
VCM
Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return

Contravisory Investment Management's NTUS Position: Q1 2018 in Review

Contravisory Investment Management sold out of Natus Medical Inc (NTUS) in Q1 2018, closing a stake of 27 shares — an estimated $1K sold.

Contravisory Investment Management first reported a position in NTUS in Q3 2017 and held it in 2 quarters. The position peaked at $1K in Q4 2017. 184 funds tracked by Wall St. Rank hold NTUS as of Q1 2018.

  • Contravisory Investment Management reported no remaining Natus Medical Inc position as of Q1 2018 after selling out during the quarter.
  • Contravisory Investment Management sold 27 Natus Medical Inc shares in Q1 2018, an estimated $1K.
  • Contravisory Investment Management first reported a position in Natus Medical Inc in Q3 2017 and held it in 2 quarters.
  • Contravisory Investment Management's Natus Medical Inc position peaked at $1K in Q4 2017.
  • 184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2018.

Based on Contravisory Investment Management's 13F filing for Q1 2018, filed 9 Apr 2018.